Davimet With Fluoride Tablet, Chewable
NDC Package 59088-170-54
Package Information
Davimet With Fluoride (multivitamin, fluoride) tablets is supplementation of the diet with ten essential vitamins.Supplementation of the diet with fluoride for caries prophylaxis.The American Academy of Pediatrics recommends that children up to age 16, in areas where drinking water contains less than optimal levels of fluoride, receive daily fluoride supplements.Davimet™ Multivitamin with Fluoride 0.75mg Chewable Tablets provide 0.75 mg fluoride in tablet form for children 6-16 years of age in areas where the drinking water fluoride level is less than 0.3 ppm. This formulation utilizes a tablet, chewable delivery system. Marketed by Puretek Corporation, this product is identified by NDC 59088-170.
Identification & Billing
Clinical Specifications
- .ALPHA.-TOCOPHEROL ACETATE, DL- 6.75 mg/1
- ASCORBIC ACID 24 mg/1
- CHOLECALCIFEROL 10 ug/1
- LEVOMEFOLATE CALCIUM 1000 ug/1
- METHYLCOBALAMIN 4.5 ug/1
- NIACIN 13.5 mg/1
- PYRIDOXINE HYDROCHLORIDE 1.05 mg/1
- RIBOFLAVIN 1.2 mg/1
- SODIUM ASCORBATE 36 mg/1
- SODIUM FLUORIDE .75 mg/1
- THIAMINE MONONITRATE 1.05 mg/1
- VITAMIN A 750 ug/1
- Analogs/Derivatives - [Chemical/Ingredient]
- Ascorbic Acid - [CS]
- Folate Analog - [EPC] (Established Pharmacologic Class)
- Folic Acid - [CS]
- Nicotinic Acid - [EPC] (Established Pharmacologic Class)
- Nicotinic Acids - [CS]
- Vitamin A - [CS]
- Vitamin A - [EPC] (Established Pharmacologic Class)
- Vitamin B 6 - [Chemical/Ingredient]
- Vitamin B6 Analog - [EPC] (Established Pharmacologic Class)
- Vitamin C - [EPC] (Established Pharmacologic Class)
- Vitamin D - [CS]
- Vitamin D - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 59088 - Puretek Corporation
- 59088-170 - Davimet With Fluoride
- 59088-170-54 - 30 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC
- 59088-170 - Davimet With Fluoride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 59088-170-54 identifies a specific commercial package of 30 tablet, chewable in 1 bottle, plastic of Davimet With Fluoride, a human prescription drug labeled by Puretek Corporation. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This tablet, chewable is formulated for oral use and contains .alpha.-tocopherol acetate, dl-; ascorbic acid; cholecalciferol; levomefolate calcium; methylcobalamin; niacin; pyridoxine hydrochloride; riboflavin; sodium ascorbate; sodium fluoride; thiamine mononitrate; vitamin a as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Puretek Corporation on February 28, 2024. The current certification is valid through December 31, 2026.
How is this Puretek Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 59088017054. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.